CD19-targeted CAR T-cell therapy for treatment-refractory autoimmune neuropathies. - Motte J; Klimas R; Sgodzai M; Schücke C; Wunsch F; Schmitz E; Rehm A; Mika T; Fisse AL; Borie D; Mougiakakos D; Haghikia A; et al. (The Lancet. Neurology, 2025)